|
COLL Collegium Pharmaceutical Inc 1267565 |
| Balance Sheet |
|
Current Assets
|
$608,014,000.00 |
|
Assets
|
$2,135,790,000.00 |
|
Current Liabilities
|
$589,861,000.00 |
|
Liabilities
|
$1,823,881,000.00 |
|
Equity
|
$311,909,000.00 |
|
Shares Out
|
32498310.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$128,436,000.00 |
|
Investing Cash Flow
|
$-500,964,000.00 |
| Market Analysis |
Market Cap
|
$895,003,457.40 |
|
Price
|
$22.77 |
|
BVPS
|
9.60 |
|
PB
|
2.87 |
|
EPS
|
-0.46 |
|
PE
|
17.97 |
|
PS
|
1.12 |
|
FCF
|
$127,670,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:25 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
2.04 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
1.76 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
1.68 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
2.25 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view COLL documents filed with the SEC.
COLL Filings
Clear
